Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, AFT Pharmaceuticals Ltd (AFT.NZ) has a market cap of $0.17 billion USD. According to our data, AFT Pharmaceuticals Ltd is ranked No.7149 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.17 B |
-6.90%
|
| Dec 31, 2024 | $0.18 B |
-16.71%
|
| Dec 29, 2023 | $0.22 B |
-3.81%
|
| Dec 30, 2022 | $0.22 B |
-18.53%
|
| Dec 31, 2021 | $0.28 B |
-18.69%
|
| Dec 31, 2020 | $0.34 B |
57.43%
|
| Dec 31, 2019 | $0.21 B |
62.79%
|
| Dec 31, 2018 | $0.13 B |
-6.52%
|
| Dec 29, 2017 | $0.14 B |
-16.36%
|
| Dec 30, 2016 | $0.17 B |
-12.97%
|
| Dec 31, 2015 | $0.19 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 GlaxoSmithKline
GSK
|
$72.40 B |
-0.002 M
|
UK
|
 Pfizer
PFE
|
$124.84 B |
0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.02 B |
-0.013 M
|
USA
|
 AstraZeneca
AZN
|
$207.74 B |
-0.008 M
|
UK
|
 Sanofi
SNY
|
$127.15 B |
3.669 B
|
France
|
 Novartis
NVS
|
$217.57 B |
1.159 B
|
Switzerland
|
 Merck
MRK
|
$191.83 B |
-0.005 M
|
USA
|
 AbbVie
ABBV
|
$300.65 B |
-0.004 M
|
USA
|
 Eli Lilly
LLY
|
$657.48 B |
0.001 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.21 B |
0.002 M
|
USA
|
 Amgen
AMGN
|
$151.67 B |
0.126 B
|
USA
|
 Teva Pharmaceutical Industries
TEVA
|
$15.44 B |
35.468 M
|
Israel
|
 Takeda Pharmaceutical
TAK
|
$46.22 B |
0.002 M
|
Japan
|
| Market Cap | = | AFT.NZ Stock Price | * | AFT.NZ Shares Outstanding |
| = | $1.59 | * | 0.10 B | |
| = | $0.17 B |